Allogeneic Hematopoietic Cell Transplantation and Cellular Therapy

Patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) generally require allogeneic hematopoietic cell transplantation (allo-HCT) for a cure, except for patients with favorable genetic genotypes such as those with core-binding factor AML. However, the use of intensive chemothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hee-Je, Weisdorf, Daniel, Gottlieb, David J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asia-Pacific Blood and Marrow Transplantation Group 2021
Materias:
State of the Art
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847286/
https://www.ncbi.nlm.nih.gov/pubmed/36713469
http://dx.doi.org/10.31547/bct-2021-014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847286/
https://www.ncbi.nlm.nih.gov/pubmed/36713469
http://dx.doi.org/10.31547/bct-2021-014

Ejemplares similares